Search

You searched for "Consent"

3014 results found

Haag-Streit UK moves to exciting new premises

19 June 2023 | Company Profiles, Research & Development
Haag Streit UK is pleased to announce that we have moved our UK headquarters from Harlow to Bishop’s Stortford.

Haag-Streit UK appoints a new Product Manager

15 August 2023 | Recruitment & Personnel
Haag Streit UK is pleased to announce the appointment of Anna Chen in the role of Product Manager.

Sight Sciences Glaucoma Fellows Academy, Birmingham

20 October 2023 | Research & Development, Recruitment & Personnel, Awards, Conferences & Anniversaries
Saturday 7 October saw Sight Sciences hold their inaugural UK Glaucoma Fellows Academy training day.

Haag-Streit Academy 2024 course schedule released – book your place now!

27 November 2023 | Awards, Conferences & Anniversaries, Research & Development
Haag-Streit Academy is pleased to launch it’s 2024 course schedule. The schedule features our popular CPD-accredited training and education events which include informative lectures and practical, hands-on workshops, delivered by industry experts.

Haag-Streit Academy celebrates 10 years of first class clinical CPD-accredited training

26 March 2024 | Company Profiles, Recruitment & Personnel, Research & Development
Haag-Streit UK is pleased to celebrate 10 years of providing high quality slit lamp, biometry and perimetry training. In 2014, the Haag-Streit Academy was born, with the launch of the first ‘Improving Outcomes’ biometry course.

Haag-Streit UK relaunches the Perkins Mk 3 hand-held applanation tonometer

10 December 2024 | Company Profiles, Research & Development
Haag-Streit UK (HS-UK), the leading manufacturer and distributor of gold-standard diagnostic and surgical devices and instruments for ophthalmologists, optometrists, and orthoptists, is pleased to announce that they have relaunched the Perkins Mk 3 hand-held applanation tonometer. Haag-Streit UK discontinued the...

Soluvos Medical provides A.R.C. Laser’s ophthalmic range in UK

29 January 2025 | Company Profiles, Contracts & Distributors
Soluvos are thrilled to announce that they now provide A.R.C. Laser’s ophthalmic range, expanding their expertise to better serve the needs of eye care professionals. Designed to meet the highest standards in precision and reliability, enabling healthcare providers to deliver...

RayOne EMV honoured with King’s Award for Enterprise

8 May 2025 | Awards, Conferences & Anniversaries
Rayner, the UK’s sole manufacturer of intraocular lenses (IOLs) and a global leader in cataract surgery solutions, has received the prestigious King’s Award for Enterprise 2025 in the Innovation category for its groundbreaking RayOne EMV lens. Launched in 2020 and...

Sight Sciences Celebrates 150th Certified UK OMNI Surgeon

13 June 2025 | Awards, Conferences & Anniversaries, Company Profiles, Research & Development
Sight Sciences is proud to announce that 150 ophthalmic surgeons in the United Kingdom are now certified to use the OMNI® Surgical System. This milestone was marked by the recent certification of Ms. Diana Urbaneja, Consultant Ophthalmic Surgeon at University...

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

14 February 2025 | research, genetics, gene therapy, pathology, education, Adeno-Associated Virus, inflammation
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

World-first platform for transparent, fair and equitable use of AI in healthcare

25 November 2025 | artificial intelligence, diabetes, diagnostics, research
Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...